Anticardiolipin and antinuclear antibodies in epilepsy - A population-based cross-sectional study

Epilepsy Research

Volumn 58, Issue 1, 2004, Pages 13-18

  Ranua, J ^a   Luoma, K ^b   Peltola, J ^c   Haapala, A M ^c   Raitanen, J ^d   Auvinen, A ^d   Isojarvi J ^b  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Anticardiolipin antibodies; Antinuclear antibodies; Autoantibodies; Epilepsy

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; B2 GLYCOPROTEIN I ANTIBODY; CARBAMAZEPINE; CARDIOLIPIN ANTIBODY; CLONAZEPAM; IMMUNOGLOBULIN G; LAMOTRIGINE; OXCARBAZEPINE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN;

ADULT; ANTIBODY DETECTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DRUG USE; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREVALENCE;

EID: 1842503787     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2003.12.004     Document Type: Article

References (28)

1. Aarli J.A. Epilepsy and the immune system. Arch. Neurol. 57:2000;1689-1692.
2. Alarcon-Segovia, D., Cabral, A.R., 1998. Antiphospholipid/cofactor syndromes. In: Rose, N.R., Mackay, I.R. (Eds.), The Autoimmune Diseases, third ed. Academic Press, San Diego, p. 305.
3. Angelini L., Granata T., Zibordi F., Binelli S., Zorzi G., Besana C. Partial seizures associated with antiphospholipid antibodies in childhood. Neuropediatrics. 29:1998;249-253.
4. Asconape J.J., Manning K.R., Lancman M.E. Systemic lupus erythematosus associated with use of valproate. Epilepsia. 35:1994;162-163.
5. Brey R.L., Escalante A. Neurological manifestations of antiphospholipid antibody syndrome. Lupus. 7(Suppl. 2):1998;67-74.
6. Eriksson K., Peltola J., Keränen T., Haapala A.M., Koivikko M. High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. Epilepsy Res. 46:2001;129-137.
7. Formiga F., Mitjavila F., Pac M., Moga I. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients. Lupus. 6:1997;486.
8. Guerin J., Feighery C., Sim R.B., Jackson J. Antibodies to B2-glycoprotein I: a specific marker for the antiphospholipid syndrome. Clin. Exp. Immunol. 198:1997;304-309.
9. Harris N., Pierangeli S., Birch D. Anticardiolipin wet workshop report. Fifth international symposium on antiphospholipid antibodies. Am. J. Clin. Pathol. 101:1994;616-624.
10. Herranz M.T., Rivier G., Khamashta M.A., Blaser K.U., Hughes G.R.V. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheumatol. 37:1994;568-571.
11. Ijdo J.W., Conti-Kelly A.M., Greco P., Abedi M., Amos M., Provenzale J.M., Greco T.P. Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnessess: MS or APS? Lupus. 8:1999;109-115.
12. Commission on Classification and Terminology of the International League Against Epilepsy, 1989. Proposal for revised clinical and electroencephalic classification of epileptic seizures. Epilepsia 30, 389-399.
13. Jain K.K. Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy. Drug Saf. 6:1991;350-360.
14. Levine R.S., Welch K.M.A. The spectrum of neurologic disease associated with antiphosholipid antibodies. Arch. Neurol. 44:1987;876-883.
15. Liou H.H., Wang C.R., Chen C.J., Chen R.C., Chuang C.Y., Chiang I.P., Tsai M.C. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus. 5:1996;307-312.
16. Ordi-Ros J., Perez-Peman P., Monasterio J. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies). Haemostasis. 24:1994;165-174.
17. Peltola J., Palmio J., Korhonen L., Suhonen J., Miettinen A., Hurme M., Lindholm D., Keränen T. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 42:2000a;201-211.
18. Peltola J.T., Haapala A.-M., Isojärvi J.I., Auvinen A., Palmio J., Latvala K., Kulmala P., Laine S., Vaarala O., Keränen T. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am. J. Med. 109:2000b;712-717.
19. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J. Autoimmunol. 15:2000;145-151.
20. Ponti F., Lecchini S., Cosentino M., Castelletti C.M., Malesci A., Frigo G.M. Immunological adverse effects of anticonvulsants. Drug Saf. 3:1993;235-250.
21. Sachse C., Lüthke K., Hartung K., Fricke M., Liedvogel B., Kalden J.R., Peter H.H., Lakomek H.J., Henkel E., Deicher H. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. Rheumatol. Int. 15:1995;23-29.
22. Shrivastava A., Dwivedi S., Aggarwal A., Misra R. Anticardiolipin and anti-beta2 glycoprotein I antibodies in Indian patiens with systemic lupus erythematosus: association with the presence of seizures. Lupus. 10:2001;45-50.
23. Slater C.A., Davis R.B., Schmerling R.H. Antinuclear antibody testing. A study of clinical utility. Arch. Intern. Med. 156:1996;1421-1425.
24. Stratton M.A. Drug induced systemic lupus erythematosus. Clin. Pharm. 4:1985;657-663.
25. Tan E.M., Feltkamp T.E., Smolen J.S., Butcher B., Dawkins R., Fritzler M.J., Gordon T., Hardin J.A., Kalden J.R., Lahita R.G., Maini R.N., McDougal J.S., Rothfield N.F., Smeenk R.J., Takasaki Y., Wiik A., Wilson M.R., Koziol J.A. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheumatol. 40:1997;1601-1611.
26. Toubi E., Munther A., Khamashta M.A., Panarra A., Hughes G.R.V. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am. J. Med. 99:1995;397-401.
27. Verrot D., San-Marco M., Dravet C., Genton P., Disdier P., Bolla G., Harle J.-R., Reynaud L., Weiller P.-J. Prevalence and significance of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am. J. Med. 103:1997;33-37.
28. Yoshimura K., Konishi T., Kotani H., Wakiguchi H., Kurashige T. Prevalence of positive anticardiolipin antibody in benign infantile convulsion. Brain Dev. 23:2001;317-320.